Check out this @oncologytube interview featuring Melinda Telli, M.D. and Erika J. Crosby, Ph.D. to learn more about the pre-clinical data in triple-negative #BreastCancer that we presented at #SITC2020: http://bit.ly/3oIkRrl
Today we entered into an agreement granting @SirtexMedical an option to co-promote our lead investigational product candidate in anti-PD-1 checkpoint refractory metastatic #melanoma. Learn more here: https://bit.ly/3bPcVkZ #BiotechNews #cancer
#ICYMI, we joined @TNBCFoundation and @touchbbca in supporting the @BlackDOCTORS event, "The Doctor Is In," where experts in #BreastCancer gave a medical update from #SABCS2020. To watch a replay of the event, click here: http://bit.ly/2W2Tw77
Adil Daud, M.D., trial investigator of our Phase 2b KEYNOTE-695 #ClinicalTrial, spoke with @oncologytube about the interim data we presented at #SITC2020 in patients with anti-PD-1 refractory advanced #melanoma. Watch the interview here: http://bit.ly/2KkWEs4